$10 = $7 market cap Just on combo approval this is not happening. Combo drug is not primary drug so the revenue will not reach for many years.
In fact we have to see if CYDY can market the product with any BP or MP. The royalty income will not be that big and with mono upcoming they will not spend much energy on combo